Malarial parasite membranes

Malarial parasite membranes refer to the distinct lipid bilayers of Plasmodium species, including the parasite plasma membrane (PPM), the parasitophorous vacuolar membrane (PVM), and the digestive vacuole (DV) membrane. These structures are essential for the parasite's survival within host erythrocytes, serving as the site for critical biological processes such as ion homeostasis, nutrient uptake, and the detoxification of heme during hemoglobin degradation (NIH, 2022). Membrane-bound proteins like PfATP4 and PfCRT are key therapeutic targets; for instance, PfATP4 inhibitors disrupt sodium homeostasis, while chloroquine acts by interfering with processes within the digestive vacuole (PubMed, 2019). Furthermore, these membranes are integral to the parasite's lifecycle, mediating the egress of merozoites and the invasion of new red blood cells (Francis Crick Institute, 2018). Therapeutic targeting of these membranes is highly effective but faces significant challenges due to the rapid evolution of resistance mutations in membrane transporters (PMC, 2020). Understanding the biophysical and biochemical properties of these membranes is therefore central to developing next-generation antimalarials that can bypass current resistance mechanisms.

Other names

Parasite plasma membrane (PPM)Parasitophorous vacuolar membrane (PVM)Digestive vacuole membrane (DVM)Food vacuole membraneInner membrane complex (IMC)

Antimalarial drugs targeting parasite membranes act through diverse mechanisms: quinolines like chloroquine concentrate in the digestive vacuole to inhibit hemozoin formation (PubMed Central, 2020); PfATP4 inhibitors (e.g., cipargamin) disrupt Na+/H+ ion gradients across the plasma membrane (NIH, 2019); and artemisinins cause widespread oxidative damage to membrane lipids and proteins. Other agents may target lipid homeostasis through proteins like PfNCR1 or inhibit the proteases required for membrane rupture during parasite egress (Heliyon, 2022).